CEO & Co-Founder
NyquistAI
Michelle Wu is the founder and CEO of NyquistAI. She has over a decade of experience in pharmaceuticals, medical technology, and digital innovation. She has been featured by Forbes, and given talks on AI in life science in various conferences. She is the author of a chapter on AI in Healthcare by MIT Press.
Before founding NyquistAI, she was the youngest global strategy manager at Novartis AG, where she worked on the very first and so far the only asset swap deal in the history of the pharmaceutical industry among Novartis, Eli Lilly, and GSK, which led her to realize the universal pain point of manual and cumbersome data research and potential pitfalls if it is not done right. This experience inspired her to build NyquistAI. Prior to Novartis, she worked for the life science practice for BCG and served big innovative pharmaceutical and Medtech companies on their global strategy, product development strategy, and emerging market strategies. She received her MBA from Stanford University and her BA from Peking University. She speaks English, Chinese, Vietnamese, Japanese, and a bit of German, given her global work experience in Asia, Europe, and now the US.
Sponsored Presentation: No hype, just help: AI tools that support your daily regulatory workflow
Thursday, October 9, 2025
10:45 AM - 11:10 AM EST